Records containing: Refractory Chronic Cough
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-07-14A Phase 3, 52-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Efficacy and Safety Study With Open-Label Extension of BLU-5937 in Adult Participants With Refractory Chronic Cough, Including Unexplained Chronic Cough (CALM-1)
-
CLINICAL_TRIALS study record update · 2026-04-15A Phase 3, 24-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Efficacy and Safety Study With Open-label Extension of BLU-5937 in Adult Participants With Refractory Chronic Cough Including Unexplained Chronic Cough (CALM-2)
-
CLINICAL_TRIALS study record update · 2026-04-14COllaboration REsearch on Chronic Cough (COREC): a French Multicenter Database
-
CLINICAL_TRIALS study record update · 2026-04-06Mechanisms of Change in Behavioral Cough Suppression Therapy for Refractory Chronic Cough
-
CLINICAL_TRIALS study record update · 2026-03-30A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Two-Period Crossover Efficacy and Safety Study of Nalbuphine ER Tablets for the Treatment of Refractory Chronic Cough
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-19A Randomized，Double-Blind, Multicenter，Placebo-Controlled, Parallel-Arm, Phase 2 Study to Evaluate the Efficacy and Safety of HW091077 in Participants With Refractory Chronic Cough or Unexplained Chronic Cough (RCC/UCC).
-
CLINICAL_TRIALS study record update · 2026-01-21A Randomized, Double-blind, Placebo-controlled, Dose-escalation Study Evaluating the Efficacy of Two Doses of Duloxetine & Amitriptyline in Subjects With Refractory Chronic Cough
-
CLINICAL_TRIALS study record update · 2026-01-21A Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled Phase II Study of Efficacy and Safety of HRS-2261 in Refractory Chronic Cough
-
CLINICAL_TRIALS study record update · 2025-12-17A 2x2 Factorial, Randomized, Open-label Trial to Evaluate Neuromodulators and Cough Control Therapy in Patients With Refractory or Unexplained Chronic Cough (FORTITUDE)
-
CLINICAL_TRIALS study record update · 2025-09-11A Prospective Decentralized Investigation of the Effect of a Cough Management Feature Inside a Wellness Application (CoughPro) in Refractory or Unexplained Chronic Cough (RCC/UCC)
-
CLINICAL_TRIALS study record update · 2025-06-10A Phase 3, 52-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Efficacy and Safety Study With Open-Label Extension of BLU-5937 in Adult Participants With Refractory Chronic Cough, Including Unexplained Chronic Cough (CALM-1)
-
CLINICAL_TRIALS study record update · 2024-11-27Group Telehealth Behavioral Cough Suppression Therapy Pilot Study
-
CLINICAL_TRIALS study record update · 2024-01-19A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase Ib/II Clinical Study to Evaluate the Efficacy, Safety and Pharmacokinetics of TCR1672 Tablets in Patients With Refractory Chronic Cough
-
CLINICAL_TRIALS study record update · 2023-03-30A Phase 1, Two Part, Placebo-controlled, Single Dose Study in Healthy Volunteers and Multiple Dose Study in Patients With Refractory Chronic Cough to Assess the Safety, Tolerability, and PK of NTX-1175 Administered Via Nebulizer (NOC-100) and Dry Powder Inhaler (NOC-110)
-
CLINICAL_TRIALS study record update · 2021-12-13A Randomized, Adaptive, Double-Blind, Placebo-Controlled, Parallel-Arm, Phase 2b Study to Evaluate the Efficacy and Safety of Multiple Doses of BLU-5937 in Adult Participants With Refractory Chronic Cough
-
CLINICAL_TRIALS study record update · 2021-02-12A Study to Assess the Effect of AF-219 on Cough Reflex Sensitivity in Both Healthy and Chronic Cough Subjects
-
CLINICAL_TRIALS study record update · 2020-10-22A Dose Escalation Study to Assess the Efficacy and Tolerance of AF-219 in Subjects With Refractory Chronic Cough
-
CLINICAL_TRIALS study record update · 2019-11-25A Randomized, Parallel, Double-Blind Study to Assess the Efficacy and Tolerability of AF-219 in Subjects With Refractory Chronic Cough
-
CLINICAL_TRIALS study record update · 2019-10-22A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
-
CLINICAL_TRIALS study record update · 2018-11-26Indomethacin for Refractory Chronic Cough: a Randomized, Double-blind, Placebo-controlled Trial
-
CLINICAL_TRIALS study record update · 2018-02-15A Study to Assess the Effect of MK-7264 (AF-219) on Cough Reflex Sensitivity in Both Healthy and Chronic Cough Subjects
-
CLINICAL_TRIALS study record update · 2018-02-14A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
-
CLINICAL_TRIALS study record update · 2016-02-22Treatment of Chronic Idiopathic Cough and Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis With PA101